Viewing StudyNCT01950273



Ignite Creation Date: 2024-05-06 @ 2:01 AM
Last Modification Date: 2024-10-26 @ 11:12 AM
Study NCT ID: NCT01950273
Status: COMPLETED
Last Update Posted: 2018-09-05
First Post: 2013-09-23

Brief Title: Pharmacokinetics and Pharmacodynamics of BI 695500 vs Rituximab as First Line-treatment in Patients With Low Tumor Burden Follicular Lymphoma
Sponsor: Boehringer Ingelheim
Organization: Boehringer Ingelheim

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-09-27
Start Date Type: ACTUAL
Primary Completion Date: 2015-12-22
Primary Completion Date Type: ACTUAL
Completion Date: 2015-12-22
Completion Date Type: ACTUAL
First Submit Date: 2013-09-23
First Submit QC Date: September 23 2013
Study First Post Date: 2013-09-25
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2018-09-05
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-09-03
Last Update Post Date: 2018-09-05
Last Update Post Date Type: ACTUAL